T1	Subject 1170 1188	healthy volunteers
T5	Subject 492 503	41 patients
T7	Subject 1019 1027	patients
T8	Disorder 304 307	IPF
T17	Disorder 1215 1218	IPF
T18	Anatomical_entity 380 385	serum
T21	GGPs 603 606	CRP
T22	Disorder 273 302	idiopathic pulmonary fibrosis
T24	GGPs 461 465	VEGF
T28	Anatomical_entity 804 816	interstitial
T33	Anatomical_entity 587 592	serum
T34	Disorder 1676 1679	IPF
T36	GGPs 112 146	Vascular endothelial growth factor
T38	Anatomical_entity 469 474	serum
T40	GGPs 22 56	vascular endothelial growth factor
T43	Anatomical_entity 1631 1636	serum
T45	Subject 66 74	patients
T46	Subject 548 569	43 healthy volunteers
T52	GGPs 148 152	VEGF
T53	GGPs 1556 1560	VEGF
T54	Anatomical_entity 825 833	alveolar
T59	Disorder 1015 1018	IPF
T65	GGPs 1283 1287	VEGF
T66	GGPs 386 390	VEGF
T68	Disorder 509 512	IPF
T71	Disorder 80 109	idiopathic pulmonary fibrosis
T76	Anatomical_entity 16 21	serum
T81	GGPs 608 611	LDH
T85	GGPs 1405 1409	VEGF
T89	Subject 514 525	14 patients
T94	GGPs 1637 1641	VEGF
T95	Disorder 531 542	lung cancer
T97	GGPs 619 623	SP-D
T100	GGPs 1000 1004	VEGF
N12	Reference T5 UMLS:C0030705	Patients
N18	Reference T7 UMLS:C0030705	Patients
N21	Reference T8 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N65	Reference T17 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N71	Reference T18 UMLS:C0229671	Serum
N81	Reference T22 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N99	Reference T28 UMLS:C0596790	interstitial
N118	Reference T33 UMLS:C0229671	Serum
N120	Reference T34 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N140	Reference T38 UMLS:C0229671	Serum
N159	Reference T43 UMLS:C0229671	Serum
N162	Reference T45 UMLS:C0030705	Patients
N186	Reference T54 UMLS:C1440080	Alveolar
N208	Reference T59 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N239	Reference T68 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N245	Reference T71 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N262	Reference T76 UMLS:C0229671	Serum
N287	Reference T81 UMLS:C0022917	Lactate Dehydrogenase
N318	Reference T89 UMLS:C0030705	Patients
N343	Reference T95 UMLS:C0242379	Malignant neoplasm of lung
N363	Reference T97 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
T101	Method_cue 716 751	High-resolution computed tomography
N2	Reference T101 UMLS:C1512457	High Resolution Computed Tomography
T16	Disorder 239 261	fibrotic lung diseases
N3	Reference T16 UMLS:C0034069	Pulmonary Fibrosis
T29	Measurement 1038 1076	alveolar-arterial difference of oxygen
N4	Reference T29 UMLS:C0429685	Alveolar-arterial oxygen tension difference
T47	Measurement 1078 1085	AaDO(2)
N8	Reference T47 UMLS:C0429685	Alveolar-arterial oxygen tension difference
T64	Measurement 1142 1149	AaDO(2)
N10	Reference T64 UMLS:C0429685	Alveolar-arterial oxygen tension difference
T73	Measurement 1486 1493	AaDO(2)
N13	Reference T73 UMLS:C0429685	Alveolar-arterial oxygen tension difference
N16	Reference T21 UMLS:C0006560	C-reactive protein
T27	GGPs 613 617	KL-6
N19	Reference T27 UMLS:C0057628	Mucin-1 protein
T48	GGPs 1347 1351	KL-6
N20	Reference T48 UMLS:C0057628	Mucin-1 protein
N22	Reference T36 UMLS:C0078058	Vascular Endothelial Growth Factor A
N23	Reference T52 UMLS:C0078058	Vascular Endothelial Growth Factor A
N25	Reference T66 UMLS:C0078058	Vascular Endothelial Growth Factor A
N28	Reference T24 UMLS:C0078058	Vascular Endothelial Growth Factor A
N29	Reference T100 UMLS:C0078058	Vascular Endothelial Growth Factor A
N32	Reference T65 UMLS:C0078058	Vascular Endothelial Growth Factor A
N33	Reference T85 UMLS:C0078058	Vascular Endothelial Growth Factor A
N37	Reference T53 UMLS:C0078058	Vascular Endothelial Growth Factor A
N38	Reference T94 UMLS:C0078058	Vascular Endothelial Growth Factor A
T80	Biological_process 176 188	angiogenesis
E3	Biological_process:T80 
N42	Reference E3 UMLS:C0302600	Angiogenic Process
N17	Reference T40 UMLS:C0078058	Vascular Endothelial Growth Factor A
T86	Subject 1219 1224	group
N39	Reference T86 UMLS:C1257890	Population Group
R1	Subject_Disorder Arg1:T45 Arg2:T71	
R2	Subject_Disorder Arg1:T5 Arg2:T68	
R3	Subject_Disorder Arg1:T89 Arg2:T95	
R4	Subject_Disorder Arg1:T7 Arg2:T59	
R5	Subject_Disorder Arg1:T86 Arg2:T17	
T44	Gene_expression 1005 1011	levels
E6	Gene_expression:T44 Theme:T100
N44	Reference E6 UMLS:C1519614	Genetic Translation Process
T88	Positive_regulation 1113 1121	elevated
E7	Positive_regulation:T88 Theme:E6 disorder:T59
N45	Reference E7 UMLS:C1879547	Activation action
N47	Reference T46 UMLS:C2986479	Healthy Control
N1	Reference T1 UMLS:C2986479	Healthy Control
T99	Biological_process 223 235	pathogenesis
E8	Biological_process:T99 Theme:T16
N48	Reference E8 UMLS:C0699748	Pathogenesis
R8	member_of Arg1:T22 Arg2:T16	
T102	Method_cue 753 757	HRCT
N49	Reference T102 UMLS:C1512457	High Resolution Computed Tomography
T103	Method_cue 1303 1307	HRCT
N50	Reference T103 UMLS:C1512457	High Resolution Computed Tomography
T96	Positive_regulation 163 172	regulator
E9	Positive_regulation:T96 Cause:T36 Theme:E3
N52	Reference E9 UMLS:C1879547	Activation action
T78	Measurement 1593 1625	percent predicted vital capacity
N53	Reference T78 UMLS:C2919340	Percentage of predicted vital capacity
T4	Biological_process 412 419;434 445	disease progression
E1	Biological_process:T4 Cue:T32
N6	Reference E1 UMLS:C0242656	Disease Progression
T9	Biological_process 1723 1744	disease's progression
E5	Biological_process:T9 
N9	Reference E5 UMLS:C0242656	Disease Progression
T23	Method_cue 658 685	arterial blood gas analysis
N30	Reference T23 UMLS:C0150411	Analysis of arterial blood gases and pH
T39	Method_cue 690 714	pulmonary function tests
N51	Reference T39 UMLS:C0024119	Pulmonary function tests
T42	Speculation_cue 574 582	measured
T10	Speculation_cue 480 488	measured
T32	Speculation_cue 401 411	evaluating
R10	part_of Arg1:T76 Arg2:T45	
A1	Speculated E1
